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Summary
 
The developmental commitment to a T helper 1 (Th1)- or Th2-type response can significantly
influence host immunity to pathogens. Extinction of the IL-12 signaling pathway during early
Th2 development provides a mechanism that allows stable phenotype commitment. In this re-
port we demonstrate that extinction of IL-12 signaling in early Th2 cells results from a selective
loss of IL-12 receptor (IL-12R) 
 
b
 
2 subunit expression. To determine the basis for this selective
loss, we examined IL-12R 
 
b
 
2 subunit expression during Th cell development in response to
T cell treatment with different cytokines. IL-12R 
 
b
 
2 is not expressed by naive resting CD4
 
1
 
T cells, but is induced upon antigen activation through the T cell receptor. Importantly, IL-4
and IFN-
 
g
 
 were found to significantly modify IL-12 receptor 
 
b
 
2 expression after T cell activa-
tion. IL-4 inhibited IL-12R 
 
b
 
2 expression leading to the loss of IL-12 signaling, providing an
important point of regulation to promote commitment to the Th2 pathway. IFN-
 
g
 
 treatment
of early developing Th2 cells maintained IL-12R 
 
b
 
2 expression and restored the ability of these
cells to functionally respond to IL-12, but did not directly inhibit IL-4 or induce IFN-
 
g
 
 produc-
tion. Thus, IFN-
 
g
 
 may prevent early Th cells from premature commitment to the Th2 path-
way. Controlling the expression of the IL-12R 
 
b
 
2 subunit could be an important therapeutic
target for the redirection of ongoing Th cell responses.
 
I
 
n chronic immune responses, cytokine production by
CD4
 
1
 
 T cells may polarize toward either a Th1 or Th2
response (1). Th1 cytokines, such as IFN-
 
g
 
 and lympho-
toxin, promote phagocytic and inflammatory responses,
whereas Th2 cytokines like IL-4, IL-5, and IL-6 promote
allergic and eosinophilic responses and provide specific B cell
help associated with IgE isotype switching (1–4). Cytokines
present in the early stages of antigen driven CD4
 
1
 
 T cell
activation help to determine the specific pattern of Th phe-
notype that develops (4). Th1 development is enhanced
when naive T cells are activated in the presence of IL-12
(5, 6). IFN-
 
g
 
 assists Th1 development initially through a
mechanism consistent with promoting the ability of naive
T cells to respond to IL-12 (7, 8). Conversely, Th2 cells
develop when IL-4 but not IL-12 is present during activa-
tion of naive T cells (5, 9). In addition, cross regulation be-
tween these subsets takes place, so that development of one
subset is inhibited by cytokines produced by the other (2, 4).
This mechanism provides one way for responses to become
self-reinforcing and helps to stabilize the emergence of po-
larized phenotypes. For example, the Th2 cytokines inter-
leukin 4 (IL-4) and IL-10 suppress Th1 development by
inhibiting production of IFN-
 
g
 
 and IL-12 (10), whereas
IFN-
 
g
 
 has been thought to selectively limit the outgrowth
of Th2 cells (11–13).
Recently, reversibility of Th2 responses has been exam-
ined both in vivo and in vitro (14–18). Th2 responses de-
veloping during infection by 
 
Leishmania major
 
 of susceptible
BALB/c mice were found to revert to healing Th1-type re-
sponses upon treatment with IL-12 and the antibiotic com-
pound Pentostam (14) or under certain conditions in mod-
els employing T cell transfers into scid mice (15). These
studies suggest that emerging Th2 responses may be revers-
ible. In vitro analysis of TCR-transgenic naive T cells
showed that emergent Th2 responses become unresponsive
to IL-12 and effectively resist reversal to Th1 phenotype
(16, 17). We partially characterized the mechanism of in
vitro resistance of Th2 cells to IL-12 as a defect in proximal
IL-12 signaling (17). T cells activated in vitro for 3 d under
strongly polarizing conditions (IL-4 and anti–IL-12) were
unable to phosphorylate Jak2, Stat1, Stat3, and Stat4 in re-
sponse to IL-12 (17). Expression of the IL-12R 
 
b
 
1 subunit
was similar in Th1 and Th2 cells, suggesting that this recep-
tor subunit was not responsible for lack of IL-12 signaling
in Th2 cells. Also, both Th1 and Th2 cells expressed simi-
lar levels of the relevant kinases, Jak2 and Tyk2 and the
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STAT proteins Stat1, Stat3, and Stat4 (17). Thus, the pre-
cise molecular basis for the signaling defect remained unclear.
We also compared loss of IL-12 responsiveness in T cells from
Balb/c (
 
L. major 
 
susceptible) and B10.D2 (
 
L. major 
 
resis-
tant) strains and found a correlation between resistance and
the maintenance of T cell IL-12 responsiveness. Thus, when
stimulated without addition of cytokines or anti-cytokine
antibodies, B10.D2 T cells maintained IL-12 responsive-
ness whereas Balb/c T cells lost IL-12 responsiveness (19).
We suggested that prolonging the period of IL-12 respon-
siveness in an emerging T cell response may allow resistant
strains to reverse the early Th2-type response toward a pro-
tective Th1 response due to the action of IL-12 generated
during the later stages of infection (19, 20). However, the
precise molecular basis for the defect in IL-12 signaling still
remained unclear (19).
Recently, a second component of the IL-12 receptor
(IL-12R)
 
1
 
 was identified and cloned. This component, the
IL-12 receptor 
 
b
 
2 subunit, is necessary for IL-12 signaling
through the Jak/STAT pathway. In the present report, we
now show that the basis for the IL-12 signaling defect in
Th2 cells is the specific down regulation of this newly
identified IL-12 receptor component, the IL-12R 
 
b
 
2 sub-
unit. To determine the basis for this selective loss, we ex-
amined IL-12R 
 
b
 
2 subunit expression in response to T cell
treatment with cytokines. IFN-
 
g
 
 treatment of Th cells de-
veloping in Th2-inducing conditions induced the expres-
sion of IL-12R 
 
b
 
2 mRNA and restored the ability of these
T cells to functionally respond to IL-12. IFN-
 
g
 
 may thus
prevent early Th cells from premature commitment to the
Th2 pathway. These results help to resolve some of the dis-
crepancies reported regarding the reversibility of ongoing
murine Th2 responses in vivo and in vitro. They may also
help to explain some of the differences observed between
murine and human Th2 cells.
 
Materials and Methods
 
Cytokines and Antibodies.
 
Recombinant human IL-2 was pro-
vided by Takeda (Osaka, Japan), recombinant murine IL-4 by
Genzyme (Cambridge, MA), recombinant murine IL-12 by
Hoffmann-La Roche (Nutley, NJ), and recombinant murine
IFN-
 
g
 
 by Genentech (South San Francisco, CA). Anti–IL-12
mAb (TOSH) was supplied by Drs. C.S. Tripp and E.R. Unanue
(Washington University School of Medicine, St. Louis, MO) (22),
anti–IFN-
 
g
 
 mAb (H22) by Dr. R.D. Schreiber (23), and poly-
clonal rabbit antiserum specific for Stat4 was provided by Dr.
James Darnell (Rockefeller University, New York, NY) (24, 25).
The anti-phosphotyrosine reagent RC20 was purchased from
Transduction Laboratories (Lexington, KY). Anti–IL-4 mAb 11B11
has been described (26).
 
Medium and Peptides.
 
T cells were maintained in IMDM
(Washington University Tissue Culture Support Center, St. Louis,
MO) supplemented as described (17). OVA peptide from chicken
ovalbumin (residues 323-339) was synthesized on an Applied
Biosystems model 430 peptide synthesizer (Foster City, CA).
 
Animals.
 
Mice transgenic for the DO11.10 
 
ab
 
-TCR (27)
were maintained on the BALB/c background. Female BALB/c mice
were purchased from Harlan Sprague Dawley (Indianapolis, IN).
 
T Cell Purification and T Cell Cultures.
 
Mel-14
 
hi
 
/CD4
 
1
 
 T cells
were isolated from spleens of 4–6 wk old unimmunized DO11.10
TCR-transgenic mice on a FACS
 
Ò
 
 Vantage cell sorter as described
(28) yielding purities of 
 
.
 
98%. 2.5
 
 3 
 
10
 
5
 
 FACS
 
Ò
 
-sorted Mel-
14
 
hi
 
/CD4
 
1
 
 DO11.10 T cells were stimulated in 2 ml cultures
with 0.3 
 
m
 
M OVA peptide presented by irradiated BALB/c sple-
nocytes (2,000 rads, 6
 
 3 
 
10
 
6
 
/well) in the presence of 10 U/ml
IL-12 and 10 
 
m
 
g/ml anti–IL-4 (11B11) to promote Th1 pheno-
type development, 200 U/ml IL-4 and 3 
 
m
 
g/ml anti–IL-12
(TOSH) to promote Th2 phenotype development, or the combi-
nation of 10 U/ml IL-12 and 200 U/ml IL-4. At 72 h the cells
were expanded threefold in fresh medium. These differentiated
Th cells were harvested on day 7, washed, and counted. 1.25
 
 3
 
10
 
5
 
 T cells were restimulated with OVA peptide and BALB/c
splenocytes with or without addition of cytokines or anti-cytokine
antibodies as indicated in the figure legends. Supernatants were
collected after 48 h and analyzed by capture ELISA for IFN-
 
g
 
 and
IL-4 (29).
For immunoprecipitations from primary stimulations, 1
 
 3 
 
10
 
6
 
Mel-14
 
hi
 
/CD4
 
1
 
 DO11.10 T cells were stimulated in 10 ml cul-
tures with OVA peptide (0.3 
 
m
 
M) and irradiated BALB/c spleno-
cytes (4
 
 3 
 
10
 
7
 
) under the indicated primary culture conditions.
At 72 h the cells were expanded 10-fold in fresh medium con-
taining 40 U/ml IL-2. On day 5 after primary stimulation, the Th
cells were washed and incubated in complete media containing
10% FCS for 3–12 h before incubation with cytokines.
 
Immunoprecipitation and Western Blot Analysis.
 
Analysis of Stat4
tyrosine phosphorylation was performed as described (30). In
brief, total cellular lysates of 1.5–2.5
 
 3 
 
10
 
7
 
 T cells were immuno-
precipitated with anti-Stat4 antisera and resolved by SDS-PAGE.
After transfer to nitrocellulose, blots were probed with RC20
(1:2,500). Blots were stripped and reprobed with anti-Stat4 antisera
(1:3,000).
 
Northern Blot Analysis.
 
Total T cell RNA was isolated from
Th1 and Th2 cells using RNAzol RNA isolation solvent (Tel-
Test, Friendswood, TX). Northern blot analysis was performed
with 15 
 
m
 
g of total RNA per lane, and membranes were sequentially
probed with the full-length murine IL-12 receptor 
 
b
 
1 subunit
cDNA (31), the full-length murine IL-12 receptor 
 
b
 
2 subunit
cDNA and the cDNAs for GAPDH (32) or pHE7 (33).
 
Results
 
The IL-12R 
 
b
 
2 Subunit Is Expressed in Th1, but not in
Th2 Cells.
 
Mel-14
 
hi
 
 CD4
 
1
 
 T cells from DO11.10 TCR-
transgenic mice were purified and activated with antigen in
the presence of IL-12 and antibodies to IL-4, or IL-4 and
antibodies to IL-12, for 7 d to generate polarized Th1 or
Th2 populations (17). Subsequently, IL-12R expression was
analyzed by Northern blotting on day 7 and 9 after second-
ary activation (Fig. 1 
 
A
 
). Th1 cells expressed the IL-12R
 
b
 
2 mRNA at high levels on these days. In contrast, IL-12R
 
b
 
2 mRNA was completely absent in Th2 cells harvested at
these same time points. As we previously observed (17),
IL-12R 
 
b
 
1 mRNA was present in both Th1 and Th2 cells
(Fig. 1 
 
A
 
, 
 
top
 
).
To determine how rapidly expression of IL-12R 
 
b
 
2
mRNA subsided during Th2 development, we induced Th1
 
1
 
Abbreviation used in this paper:
 
 IL-2R, IL-12 receptor. 
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and Th2 differentiation from naive CD4
 
1
 
 T cells and ana-
lyzed IL-12R 
 
b
 
2 expression on days 3, 5, and 7 after pri-
mary activation. To test expression in naive T cells, we ob-
tained naive CD4
 
1
 
 T cells by cell sorting and prepared
mRNA for Northern analysis (Fig. 1 
 
B
 
). Neither IL-12R
 
b
 
1 nor IL-12R 
 
b
 
2 mRNA was detectable in naive T cells
(Fig. 1 
 
B
 
). On days 3, 5, and 7 after primary activation, de-
veloping Th1 cells expressed high levels of both the IL-12R
 
b
 
1 and IL-12R 
 
b
 
2 mRNA (Fig. 1, 
 
B
 
 and 
 
C
 
). On day 3,
Th2 cells expressed IL-12R 
 
b
 
1 mRNA at comparable or
slightly higher levels than Th1 cells, but expressed only very
low levels of IL-12R 
 
b
 
2 mRNA (Fig. 1 
 
C
 
). By days 5 and 7
after primary activation IL-12R 
 
b
 
2 mRNA was undetect-
able in Th2 cells (Fig, 1 
 
C
 
).
 
IL-4 and IFN-
 
g
 
 Regulate Functional Responsiveness to IL-12.
 
We next asked what conditions controlled the maintenance
of IL-12 signaling in developing Th cells. IL-4 was thought
to dominate IL-12 for effects on T helper phenotype de-
velopment (5, 34), since the addition of IL-4 and IL-12 to-
gether led to Th2 development both in TCR-transgenic
and anti-CD3 driven systems (5, 34). We first wished to
determine if it was the lack of IL-4 in primary cultures that
allowed the maintenance of IL-12 responsiveness in devel-
oping Th1 cells. Thus, we activated naive T cells in the pres-
ence of IL-4 and IL-12 together in the primary culture and
assessed IL-12 responsiveness on day 5 after primary stimu-
lation (Fig. 2). Surprisingly, these T cells were able to phos-
phorylate Stat4 upon IL-12 treatment (Fig. 2, 
 
middle
 
), simi-
lar to Th1 cells (Fig. 2, top), but unlike IL-12 unresponsive
Th2 cells (Fig. 2, bottom). This maintenance of Stat4 phos-
phorylation correlated with functional IL-12 responses in
these T cells as measured by IL-12–induced IFN-g pro-
duction (Fig. 3). T cells arising from stimulation in IL-4
and IL-12 together showed significant IL-12 induced IFN-g
production during restimulation (Fig. 3, top). Restimula-
tion of these cells without exogenously added IL-12 led to
production of 180 U/ml IFN-g, while addition of IL-12
increased IFN-g production to 400 U/ml. Because these T
cells arose in IL-4, they acquired the Th2-type property of
producing IL-4 and IL-10, two cytokines which inhibit
IFN-g production (35, 36). In this system, IL-10 could also
be produced by other cells used as APCs. Neutralization of
IL-4 and IL-10 revealed a significantly increased IL-12–
mediated induction of IFN-g, from less than 50 U/ml of
IFN-g produced upon restimulation in the absence of IL-12
to 1,300 U/ml of IFN-g produced in the presence of IL-12
(Fig. 3, top). In contrast, the control Th2 cells produced
very low amounts of IFN-g (20 U/ml) upon restimulation
in the presence of IL-12, a level which was not increased
by neutralization of IL-4 and IL-10 (Fig. 3, bottom). Taken
together, these results therefore suggest that the presence of
IL-12 during primary T cell activation, not the absence of
IL-4, was responsible for maintenance of functional re-
sponsiveness to IL-12.
We suspected that IL-12 was not the primary stimulus
for induction of the IL-12R b2 subunit, since a cytokine
cannot signal unless its receptor is already expressed at some
level on the cell surface. Previously, IFN-g has been shown
to be required for IL-12–induced Th1 development from
naive BALB/c T cells (7, 34). IL-12 is known to induce
Figure 1. IL-12R b2 subunit mRNA is detected in Th1 but not Th2 cells. (A) Naive CD41 T cells were purified by FACSÒ from unimmunized
DO11.10 TCR-transgenic mice as described in Materials and Methods (5), activated with OVA peptide and APCs under either Th1- or Th2-inducing con-
ditions and allowed to develop for 7 days. On day 7, the Th1 and Th2 cells were washed, restimulated and allowed to proliferate for 7 or 9 d when cells
were harvested and total cellular RNA was isolated. As tissue controls, total cellular RNA was isolated from the B cell hybridoma TA3 and the fibroblast
cell line L929. Northern blot analysis was performed using as probes the full-length murine IL-12R b2 subunit cDNA (top), the full-length murine IL-12R
b1 subunit cDNA (middle), and the GAPDH cDNA (bottom). (B and C). Total cellular RNA was isolated from naive T cells after purification by FACSÒ.
Naive T cells isolated by cell sorting were activated to induce Th1 or Th2 development, and harvested on days 3, 5, and 7 after primary antigen activa-
tion. Total cellular RNA was examined by Northern analysis as described above for IL-12R b2 subunit cDNA (top), the IL-12R b1 subunit cDNA (mid-
dle), or pHE7 cDNA (bottom).820 IL-12 Receptor Regulation During Th Development
IFN-g production from CD41 and CD81 T cells, as well
as NK cells. Since these cells are present in the irradiated
splenocytes used as APCs, we suspected that IFN-g could
be inducing the expression of the IL-12R b2 subunit. To
test this possibility, combinations of IL-12, IFN-g and IL-4,
or the corresponding neutralizing antibodies were added
during primary T cell activation and the IL-12 responsive-
ness of these developing Th cells was analyzed by measur-
ing IL-12–induced Stat4-phosphorylation on day 5 after
activation (Fig. 4). Th cells activated in the presence of
both IL-12 and IL-4 maintained IL-12-induced Stat4 phos-
phorylation (Fig. 4, lane 4). The maintenance of IL-12 re-
sponsiveness on these cells was completely dependent on the
production of endogenous IFN-g during primary activation,
since neutralization of IFN-g abolished IL-12–induced Stat4
phosphorylation (Fig. 4, lane 5). Under Th2 inducing con-
ditions (IL-4 and anti–IL-12), Th2 cells lost the ability to
phosphorylate Stat4 in response to IL-12 (Fig. 4, lane 7).
However, addition of IFN-g to this culture restored IL-12-
induced Stat4 phosphorylation (Fig. 4, lane 9). Finally, un-
der Th1 inducing conditions (IL-12 and anti–IL-4), T cells
retained the ability to phosphorylate Stat4 in response to
IL-12 in a manner that was independent of IFN-g (Fig. 4,
lanes 1–3). In summary, (a) the presence of IL-4 during
primary activation inhibits IL-12 signaling in developing
Th cells, and (b) IFN-g is able to override this inhibition
and restore IL-12 signaling in early Th cells.
IL-4 and IFN-g Regulate Expression of the IL-12R b2 Sub-
unit. To test whether IFN-g–induced restoration of IL-12
signaling involved induction of the IL-12R b2 subunit, we
performed Northern blot analysis of Th cells derived under
Figure 2. Activation in the presence of IL-4 and IL-12 results in the
maintenance of the IL-12 signaling pathway. FACSÒ-sorted naive CD41
DO11.10 T cells were cultured with OVA peptide and irradiated BALB/c
splenocytes in the presence of 10 U/ml IL-12 and 10 mg/ml anti–IL-4 to
promote Th1 differentiation (upper), 10 U/ml IL-12 and 200 U/ml IL-4
(middle), or 200 U/ml IL-4 and 3 mg/ml anti–IL-12 to promote Th2 dif-
ferentiation (bottom). After 72 h the cells were expanded 10-fold in fresh
medium containing 40 U/ml IL-2. On day 5 after primary antigen activa-
tion whole cell lysates from developing T cells (1.5–2.0 3 107) were pre-
pared after incubation for 25 min with medium alone or with 10 U/ml
IL-12. Lysates were immunoprecipitated with Stat4 antiserum, separated
by SDS-PAGE (7% gel), transferred to nitrocellulose, and probed with
the anti-phosphotyrosine reagent RC20 as described (30). After exposure,
blots were stripped and reprobed with anti-Stat4 antisera.
Figure 3. Activation in the
presence of IL-4 and IL-12 re-
sults in the maintenance of func-
tional IL-12 responsiveness.
FACSÒ-sorted naive CD41
DO11.10 T cells were cultured
for seven days with OVA pep-
tide and irradiated BALB/c sple-
nocytes under the indicated pri-
mary culture conditions. Cultures
were harvested on day 7, washed,
and restimulated at 1.25 3 105 T
cells/well with OVA peptide and
BALB/c splenocytes in the pres-
ence of the indicated cytokines
or anti-cytokine antibodies. Su-
pernatants collected after 48 h
were analyzed by ELISA for
IFN-g.821 Szabo et al.
the various conditions described in Fig. 4. T cells activated
in the presence of both IL-4 and IL-12 expressed the IL-12R
b2 mRNA (Fig. 5, lane 4). This expression was dependent
on endogenous IFN-g production, since neutralization of
IFN-g in the primary culture led to the disappearance of
IL-12R b2 mRNA (Fig. 5, lane 3). T cells arising from
stimulation in the presence of IL-4, anti–IL-12 mAb and
exogenous IFN-g added during primary activation expressed
high levels of the IL-12R b2 mRNA (Fig. 5, lane 6). Ad-
dition of anti–IFN-g mAb blocked expression of IL-12R
b2 mRNA (Fig. 5, lane 5). Th1 cells, arising from stimula-
tion in the presence of IL-12 plus anti–IL-4 mAb, expressed
IL-12R b2 mRNA independently of IFN-g (Fig. 5, lanes 1
and 2). Thus, in each case, IL-12-inducible Stat4 phosphor-
ylation (Fig. 4) correlated with expression of the IL-12R
b2 mRNA (Fig. 5).
To examine whether IFN-g treatment of developing Th
cells during primary culture altered functional responses to
IL-12, we measured the IL-12–dependent IFN-g produc-
tion in developing Th cells derived under the same condi-
tions used in Fig. 5. Additionally, since production of en-
dogenous IL-4 and IL-10 production by these cells directly
inhibits IFN-g production, we neutralized these cytokines
to more clearly assess the true potential of these cells for
IL-12 induced IFN-g production. T cells arising from
stimulation in IL-4 plus anti–IL-12 plus IFN-g responded
to IL-12 by producing 550 U/ml of IFN-g in the second-
ary stimulation (Fig. 6, top), whereas addition of anti–IFN-g
mAb led to cells producing less than 50 U/ml of IFN-g
upon restimulation (Fig. 6, bottom). For T cells treated with
IL-4 and IL-12 during primary activation, IFN-g in the
primary culture was required for IL-12 induced IFN-g pro-
duction upon secondary stimulation (Fig. 6, compare col-
umn 3 in top and bottom). For Th1 cells, arising from
stimulation in the presence of IL-12 and anti–IL-4 mAbs,
IFN-g was not required for subsequent development of IL-12
responsiveness (Fig. 6, compare column 1 in top and bot-
tom). Thus, IFN-g regulates IL-12 responsiveness with the
same pattern as it regulates IL-12R b2 expression in devel-
oping Th cells (Fig. 5).
Discussion
The data presented in this report provide a molecular ba-
sis for the previously described IL-12 unresponsiveness of
Th2 cells and help explain several discrepancies that be-
come apparent when comparing murine and human Th2
cells. Expression of the IL-12R b2 subunit is required for
recruitment and activation of the STAT proteins involved
in IL-12 signaling (37). When IL-4 is neutralized by anti-
bodies, TCR-activation alone is sufficient for inducing
IL-12R b2 expression. However, when even low levels of
IL-4 are present, expression of the IL-12R b2 is inhibited.
Thus, during in vitro Th2 development, IL-12R b2 ex-
pression is strongly inhibited by the IL-4 that is added to
induce Th2 development. This inhibition leads to loss of
IL-12 signaling capacity and helps to stabilize the emergent
Figure 4. IFN-g restores the IL-12 signaling pathway in developing
Th2 cells. FACSÒ-sorted naive CD41 DO11.10 T cells were cultured
with OVA peptide and irradiated BALB/c splenocytes under the condi-
tions indicated. In the primary cultures, IFN-g levels were either unal-
tered (none), neutralized with 30 mg/ml of the anti–IFN-g mAb H22
(anti–IFN-g) or 100 U/ml of IFN-g (IFN-g) were added as indicated.
On day 5 after primary antigen activation whole cell lysates from devel-
oping T cells (20 3 106) were prepared after incubation for 25 min with
10 U/ml IL-12. Lysates were immunoprecipitated with Stat4 antiserum,
separated by SDS-PAGE (7% gel), transferred to nitrocellulose, and probed
with the anti-phosphotyrosine reagent RC20. After exposure, blots were
stripped and reprobed with anti-Stat4 antisera. Figure 5. Regulation of IL-12R b2 subunit mRNA expression by
IFN-g. FACSÒ-sorted naive CD41 DO11.10 T cells were cultured with
OVA peptide and irradiated BALB/c splenocytes under conditions indi-
cated. On day 5 after primary antigen activation total cellular RNA was
isolated from the developing Th cells. Sequential Northern blot analysis
was performed using as probes the full-length murine IL-12R b2 subunit
cDNA (top), the full-length murine IL-12R b1 subunit cDNA (middle),
and the GAPDH cDNA (bottom).822 IL-12 Receptor Regulation During Th Development
Th2 response against reversal of phenotype upon subse-
quent IL-12 exposure. Loss of IL-12 responsiveness may
thus be an early step in the commitment of T cells to the
Th2 pathway.
Regarding the role of IFN-g in Th development, we
find that IFN-g overrides the IL-4–induced inhibition of
IL-12R b2 expression. Thus, in T cells arising from stimu-
lation with IL-4 and anti–IL-12 mAbs (i.e., fully Th2 in-
ducing conditions), IFN-g treatment during primary acti-
vation restored IL-12R b2 expression and functional IL-12
responsiveness. These T cells could produce IL-4 and IL-10
but retained the capacity for IL-12–induced IFN-g pro-
duction. The ability of Th2 cells to respond to IL-12 has
previously been described for human (38, 39), but not mu-
rine Th2 cells (16, 17). This discrepancy can now be ex-
plained as follows. Murine Th2 cells lose expression of the
IL-12R b2 due to the absence of IFN-g in Th2 cultures.
Human Th2 cells, on the other hand, express low but
functional levels of the IL-12R b2 subunit, and human
IL-12 R b2 expression is induced by IFN-a rather than
IFN-g (Francesco Sinigaglia, personal communication).
Elucidation of the molecular basis for this distinct form of
regulation between these two species will require the direct
examination of the promoter/enhancer regions of the re-
spective IL-12R b2 gene.
Our data also further clarify the role of IFN-g in Th1
development. Results from several previous reports (7, 40)
indicated that IFN-g, although by itself not sufficient, was
clearly required for IL-12–induced Th1 development from
naive T cells. Other studies however did not identify such a
requirement, even though similar TCR-transgenic experi-
mental systems were used (41). This apparent discrepancy
can now be explained by the established difference in IL-4
production that occurs in the two experimental mouse strains
used. Studies that did not identify this requirement used
TCR-transgenic mice on the C57/BL6 background in which
very little IL-4 is produced (19, 28). The substantial amount
of IL-4 produced by the BALB/c strain inhibits expression
of IL-12R b2 and imposes the observed requirement for
IFN-g that allows IL-12R b2 expression (Guler, M., N. Ja-
cobson, U. Gubler, K. Murphy, manuscript in preparation).
In the C57 or B10 backgrounds, the absence of IL-4 allows
IL-12R b2 expression to occur independently of IFN-g.
In this report IFN-g was not required for the expression
of the IL-12 receptor b2 subunit on T cells differentiated to
the Th1 phenotype with IL-12 and anti–IL-4. This result
may be due to the complete absence of IL-4 in these pri-
mary cultures, thus artificially creating C57/BL6 or B10-like
conditions. Moreover, when Th1 differentiation was in-
duced using either IL-12 alone or IL-12 plus a low level of
IL-4 (2–5 U/ml) in the primary stimulation, a requirement
for IFN-g during the primary activation for Th1 develop-
ment was observed (data not shown). Thus a requirement
for IFN-g during Th1 development may only be evident
in situations where low levels of IL-4 are present. In con-
trast, when IL-4 is absent during primary stimulation IFN-g
is not required for maintenance of the IL-12R b2 subunit
on developing Th cells.
Finally, our results may be relevant for understanding re-
sponses to certain intracellular pathogens. For example, re-
sistance to L. major in various strains of mice is complex and
probably controlled by several genetic loci. The present study
implies that cytokines could act to promote either suscepti-
bility or resistance to pathogens by their distinct actions on
IL-12R b2 expression. IL-4 inhibits expression of the
IL-12R b2 subunit and imposes a requirement for IFN-g
to maintain IL-12 responsiveness. Thus, when IFN-g pro-
duction is limited, IL-4 production in early responses may
critically inhibit IL-12R b2 expression, with significant
impact on development of protective responses. In strains
that produce IL-4 early, IFN-g production may be critical
for inducing IL-12R b2 expression on T helper cells to al-
low for IL-12–induced Th1 differentiation. NK cells may
be an important in vivo source of such early IFN-g pro-
duction, since IFN-g can be induced by the action of IL-12
and TNF on NK cells (42). As suggested by studies of the
development of resistance to L. major (43, 44), NK cells
may thus play an important role in Th1 development.
Figure 6. Examination of the functional IL-12 responses of developing
Th cells. FACSÒ-sorted naive CD41 DO11.10 T cells were cultured with
OVA peptide and irradiated BALB/c splenocytes in the presence of the
primary culture conditions indicated. Cultures were harvested on day 7,
washed, and restimulated at 1.25 3 105 T cells/well with OVA peptide
and BALB/c splenocytes in the presence of anti–IL-4 mAb (10 mg/ml
11B11) and anti IL-10 (20 mg/ml 2A5) and either IL-12 (10 U/ml) or
anti–IL-12 (3 mg/ml TOSH). Supernatants collected after 48 h were ana-
lyzed by ELISA for IFN-g.823 Szabo et al.
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